Steven Daines, MD
Orthopaedic Surgery · Boise, IDNPI 1326289364
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Stryker accounts for 86.6% of it on its own, with 8 other manufacturers making up the rest.
Across 101 payments — averaging $95.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$8K
- Medtronic$410
- Hikma Pharmaceuticals USA$344
- Zimmer Biomet$260
- Medacta USA, Inc.$115
- Smith+Nephew$108
- plus $55 from 3 others
What the payments were for
- Consulting fees$3444%
- Travel & lodging$3,75739%
- Food & beverage$5,50657%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 87 | $8,314 |
| Medtronic(2 entities) | 5 | $410 |
| Hikma Pharmaceuticals USA | 1 | $344 |
| Zimmer Biomet | 3 | $260 |
| Medacta USA, Inc. | 1 | $115 |
| Smith+Nephew | 1 | $108 |
| Total Joint Orthopedics, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $16 |
| KCI USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$5,279
- TRIATHLON$445
- COMBOGESIC IV$344
- INSIGNIA$309
- ACCOLADE$170
- RESTORATION$159
- PlasmaBlade$158
- TRIDENT$150
- X3$150
- Persona$125
- AMISTEM$115
- AQUAMANTYS$115
- Journey II CR$108
How this compares
$9,606 in reported general payments places this provider in the 65th percentile of 139 orthopaedic surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tranexamic Acid | 67 | $1,270 |
| Famotidine | 97 | $775 |
| Doxycycline Hyclate | 104 | $772 |
| Ondansetron OdtOndansetron | 105 | $744 |
| Meloxicam | 120 | $302 |
| Tramadol Hcl | 99 | $287 |
| Baclofen | 128 | $273 |
| Oxycodone Hcl | 86 | $171 |
| Amoxicillin | 36 | $41 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Boise
- Richard MooreBoise$7.4M
- Roman SchwartsmanBoise$358K
- Jeffry MenznerBoise$194K
- Christopher HiroseBoise$182K
- Joseph LynchBoise$140K
- Tracye LawyerBoise$129K
- Jared JohnsonBoise$82K
- Andrew CurranBoise$34K
- Michael CurtinBoise$33K
- Ronald KristensenBoise$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.